Trial Details

COMPLETED
Basic Information
Clinical ID c4307
Identifier NCT00724958
Trial Title Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions BIOLOGICAL: Infliximab
Participant Information
Sponsor Merck Sharp & Dohme LLC
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2004-12
Primary Completion Date 2010-07
Completion Date 2010-07